CASC3 and Miyoshi myopathy: Finally, MM xenograft model confirmed above findings in vivo and demonstrated that upregulation of AHSA1 promoted MM cell growth and BTZ resistance in vivo (Fig. 2M & Supplementary Fig. 1D-F).